Innoviva (INVA) Tops Q1 EPS by 28c

Innoviva (NASDAQ: INVA) reported Q1 EPS of $0.51, $0.28 better than the analyst estimate of $0.23. Revenue for the quarter came in at $76.37 million versus the consensus estimate of $61.46 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• Oppenheimer Starts Teva Pharma (TEVA) at Outperform
• Ennis (EBF) Misses Q2 EPS by 2c